View a Symplicity Spyral™ RDN system with a blue and green decorative spiral around it.

Symplicity™ blood pressure procedure

Thank you.

You are now signed up to receive email updates about the Symplicity™ blood pressure procedure.

Indications, Safety, and WarningsIndications for useThe Symplicity Spyral™ renal denervation system is indicated to reduce blood pressure as an adjunctive treatment in patients with hypertension in whom lifestyle modifications and antihypertensive medications do not adequately control blood pressure. ContraindicationsThe Symplicity Spyral™ system is contraindicated in patients with any of the following conditions:

Renal artery diameter < 3 mm or > 8 mm

Renal artery fibromuscular dysplasia (FMD)

Stented renal artery (< 3 months prior to RDN procedure)

Renal artery aneurysm

Renal artery diameter stenosis > 50%

Pregnancy

Presence of abnormal kidney (or secreting adrenal) tumor

Iliac/femoral artery stenosis precluding insertion of the catheter

Warnings and precautionsA thorough understanding of the technical principles, clinical applications, and risks associated with vascular access techniques and percutaneous transluminal catheterization in renal arteries is necessary before using this device.  The safety and efficacy of the Symplicity Spyral™ system has not been established in patients with isolated systolic hypertension or in patients with prior renal artery interventions including renal stents, renal angioplasty, or prior renal denervation. The Symplicity Spyral™ system has not yet been studied in patients who are breastfeeding, under the age of 18, or with secondary hypertension.

Avoid treatment with the Symplicity Spyral™ catheter within 5 mm of any diseased area or stent.

Implantable pacemakers (IPGs) and implantable cardioverter defibrillators (ICDs) or other active implants may be adversely affected by RF ablation. Refer to the implantable device’s Instructions for Use.

The patient’s heart rate may drop during the ablation procedure.

Proper pain medication should be administered at least 10 min before ablating renal nerves.

Potential adverse events Potential adverse events associated with use of the renal denervation device or the interventional procedures include, but are not limited to, the following conditions:

Allergic reaction to contrast

Arterial damage, including injury from energy application, dissection, or perforation

Arterial spasm or stenosis

Arterio-enteric fistula

AV fistula

Bleeding

Blood clots or embolism

Bruising

Cardiopulmonary arrest

Complications associated with medications commonly utilized during the procedure, such as narcotics, anxiolytics, or other pain or anti-vasospasm medications

Death

Deep vein thrombosis

Edema

Electrolyte imbalance

Heart rhythm disturbances, including bradycardia

Hematoma

Hematoma — retroperitoneal

Hematuria

Hypertension

Hypotension (may cause end organ hypoperfusion)

Infection

Kidney damage including renal failure or perforation

Myocardial infarction

Nausea or vomiting

Pain or discomfort

Peripheral ischemia

Pulmonary embolism

Proteinuria

Pseudoaneurysm

Radiocontrast nephropathy

Renal artery aneurysm

Skin burns from failure of the dispersive electrode pad

Stroke

Other potential adverse events that are unforeseen at this timePlease reference appropriate product  Instructions for Use and User Manual for more information regarding indications, contraindications, warnings, precautions, and potential adverse events. Caution: Federal (United States) law restricts this device to sale by or on the order of a physician.For further information, please call and/or consult Medtronic at 800-633-8766 or the Medtronic website at medtronic.com.UC202405768a EN

You will soon begin receiving periodic emails.

This is only the beginning. Look out for emails about the Symplicity™ blood pressure procedure, which uses the Symplicity Spyral™ renal denervation (RDN) system. In the meantime, explore content and resources currently available through the links at the bottom of this page.

Browse education and resources.

Whether you’re just learning about the Symplicity™ procedure or already familiar, we have resources for you.

View resources

View patient selection criteria.

Learn how to identify the appropriate patients for the Symplicity™ procedure.

See patient selection

Connect with a Symplicity™ representative.

Review clinical evidence, patient selection criteria, training requirements, and more.

Connect with a rep

Review product details.

Get an understanding of specifications and how the system components work together during the procedure.

See details

First Name

Last Name

Hospital Or Organization

Job Role

Specialty

Confirm country/region

Just to confirm, is this the product or product type that interests you?

{{productNamePlaceholder}}

This is intended for non-urgent inquiries only.
If you have a medical emergency, call 911 immediately.
If you have medical questions, contact your doctor.

Confirm country/region

Before we get started, what best describes you?

This is intended for non-urgent inquiries only.
If you have a medical emergency, call 911 immediately.
If you have medical questions, contact your doctor.

Confirm country/region

Before we get started, what best describes you?

First Name

Last Name

Hospital Or Organization

HOSPITAL POSTAL CODE

Job Role

Specialty

First Name

Last Name

PHONE

Hospital Or Organization

HOSPITAL POSTAL CODE

Job Role

Specialty

First Name

Last Name

PHONE

Hospital Or Organization

COUNTRY

HOSPITAL POSTAL CODE

Job Role

Specialty

First Name

Last Name

Hospital Or Organization

Country

HOSPITAL POSTAL CODE

Job Role

Specialty

Thank you.

You will soon begin receiving periodic emails.

Browse education and resources.

View patient selection criteria.

Connect with a Symplicity™ representative.

Review product details.

United States

Customer Care Team